Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Enovix Corp
Report date February 01, 2023 · Filed February 07, 2023
Section 16 reporting ended · disclosed 2023-02-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 859,075 |
Reported balance
After 2023-02-01 transaction · row 1
1 source rowRow 1 · 2023-02-01 · Tax withholding · Disposed 11,904 · Balance 859,075 F1: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on February 1, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on February 1, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2023 Filed Feb 7, 2023 23:15 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 11,904 | $8.20 | $97,612.80 |
DisclosureSEC source: 0001828318-23-000031 · wf-form4_167581169723724.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 859,075 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on February 1, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 01, 2022 Filed Nov 4, 2022 00:09 UTC | Enovix Corp ENVX · Entity 5188 | SaleCommon Stock | 30,000 | $18.55 | $556,500.00 |
DisclosureSEC source: 0001828318-22-000064 · wf-form4_166752054502983.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899,565 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.26 to $19.24, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 59,656 shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:38 UTC | Enovix Corp ENVX · Entity 5188 | SaleCommon Stock | 3,802 | $18.52 | $70,413.04 |
DisclosureSEC source: 0001828318-22-000047 · wf-form4_166500226352417.xml · nonDerivative · entry 2 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 929,565 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.47 to $18.59, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 59,656 shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:38 UTC | Enovix Corp ENVX · Entity 5188 | SaleCommon Stock | 26,198 | $17.96 | $470,516.08 |
DisclosureSEC source: 0001828318-22-000047 · wf-form4_166500226352417.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,367 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.47 to $18.465, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 59,656 shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 21:22 UTC | Enovix Corp ENVX · Entity 5188 | SaleCommon Stock | 30,000 | $20.67 | $620,100.00 |
DisclosureSEC source: 0001828318-22-000037 · wf-form4_166215370382955.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 959,565 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.31 to $21.39, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 59,656 shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 21:45 UTC | Enovix Corp ENVX · Entity 5188 | SaleCommon Stock | 10,000 | $20.00 | $200,000.00 |
DisclosureSEC source: 0001828318-22-000021 · wf-form4_166034068514755.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989,565 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 59,656 shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock. Read SEC document |
| August 05, 2022 Filed Aug 6, 2022 00:44 UTC | Enovix Corp ENVX · Entity 5188 | SaleCommon Stock | 50,000 | $14.00 | $700,000.00 |
DisclosureSEC source: 0001828318-22-000007 · wf-form4_165974667389005.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999,565 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $14.00 to $14.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 59,656 shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock. Read SEC document |
| June 06, 2022 Filed Jun 9, 2022 00:20 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 59,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035256 · doc4.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049,565 F1 · shares: Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on the first anniversary of the date of grant (the "Vesting Commencement Date"); and the remainder will vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| May 20, 2022 Filed May 24, 2022 23:36 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 2,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031752 · doc4.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,817 F1 · shares: The Reporting Person received a fully vested award of 2,214 restricted stock units on May 20, 2022. Each restricted stock unit represents a right to receive one share of the Issuer's common stock. Read SEC document |
| May 20, 2022 Filed Jun 9, 2022 00:12 UTC Amendment | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 908 | $9.31 | $8,453.48 |
DisclosureSEC source: 0001209191-22-035250 · doc4a.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989,909 F1 · kind: On May 24,2022, the Reporting Person filed a Form 4 which inadvertently neglected to report the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the fully vested award of 2,214 restricted stock units on May 20, 2022. Each restricted stock unit represented the right to received one share of the Issuer's common stock. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 21:27 UTC | Enovix Corp ENVX · Entity 5188 | GrantStock Option (Right to Buy) · Derivative | 3,939 | $0.00 Strike: $15.47 | $0.00 |
DisclosureSEC source: 0001209191-22-020579 · doc4.xml · derivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,939 Underlying: Common Stock · 3,939 shares Expires 2032-03-17 F1 · derivative.exercise_date: The shares subject to the option are fully vested on the date of grant. Read SEC document |
| July 14, 2021 Filed Jul 17, 2021 00:57 UTC | Enovix Corp ENVX · Entity 5188 | GrantStock Option (Right to Buy) · Derivative | 110,176 | Not disclosed Strike: $9.26 | Not disclosed |
DisclosureSEC source: 0001209191-21-047044 · doc4.xml · derivative · entry 3 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,176 Underlying: Common Stock · 110,176 shares Expires 2031-04-19 F1 · kind: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. F5 · price: Received in exchange for a stock option to purchase 596,800 shares of Legacy Enovix Common Stock. F4 · derivative.exercise_date: The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date. Read SEC document |
| July 14, 2021 Filed Jul 17, 2021 00:57 UTC | Enovix Corp ENVX · Entity 5188 | GrantStock Option (Right to Buy) · Derivative | 13,845 | Not disclosed Strike: $0.05 | Not disclosed |
DisclosureSEC source: 0001209191-21-047044 · doc4.xml · derivative · entry 2 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,845 Underlying: Common Stock · 13,845 shares Expires 2027-12-13 F1 · kind: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. F3 · price: Received in exchange for a stock option to purchase 75,000 shares of Legacy Enovix Common Stock. F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date. Read SEC document |
| July 14, 2021 Filed Jul 17, 2021 00:57 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 988,603 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-047044 · doc4.xml · nonDerivative · entry 1 Dales Gardner Cameron · CIK 0001868718 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988,603 F1 · kind: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. F1 · price: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.